Reacciones adversas a fármacos antituberculosos en pediatría: A propósito de 4 hermanos / Adverse Reactions to Antituberculosis Drugs in Pediatrics. Apropos of 4 Brothers
Rev. am. med. respir
; 16(3): 273-278, set. 2016. tab
Article
in Es
| LILACS
| ID: biblio-843001
Responsible library:
AR423.1
RESUMEN
Se denomina efecto adverso a fármacos antituberculosos (RAFAs), a una respuesta nociva y no deseada de uno o varios de los fármacos utilizados, para profilaxis, diagnostico o tratamiento de la enfermedad tuberculosa. Para adjudicarlos a la medicación se debe tener en cuenta que las dosis sean adecuadas, descartar interacciones medicamentosas y comorbilidades. Es necesario conocerlos y monitorizarlos, para evitar posibles riesgos de morbi-mortalidad. Objetivo:
comunicar el caso de 4 hermanos que presentaron RAFAs, a más de 1 fármaco antituberculoso.ABSTRACT
It is called tuberculous adverse drug effect (RAFAs), to a noxious response and not desired to one or more of the drugs used for prophylaxis, diagnosis or treatment of tuberculous disease. To attribute them to the medication, it is necessary to take into account that doses should be normal; also dismiss drug interactions and co-morbidities. It is necessary to know them and monitor them, to avoid possible risks of morbidity and mortality. Objective:
to communicate the case of four brothers who presented RAFAs, to more than one TB drug.Key words
Full text:
1
Index:
LILACS
Main subject:
Tuberculosis
/
Blood Platelet Disorders
/
Hepatitis
Language:
Es
Journal:
Rev. am. med. respir
Journal subject:
MEDICINA
/
PNEUMOLOGIA
Year:
2016
Type:
Article